WLD

7.50%

4.3¢ wellard limited

Wellard Foreign exchange loss, page-2

First 2 Last

gttrain

9,428 Posts.

08/06/16

09:44

Post #: 17980045

Originally posted by Hed Fundger ↑

Hey there,

I have started to recently follow this stock but have some hesitations to buy in. My main concern lies not in company’s ability to generate revenue, which it has done well y-o-y, but its ability to keep it costs down. I want to draw attention that company only broke into net profit during FY14 & FY12 and had to raise cash in order to pay its debt as it was hovering over insolvency. I see the main reason why business is not doing so well not in its finance costs, which are normal when you are expanding your business, but in its forex losses. To make things simple I did a small table below with its NPAT and foreign exchange loss for the last 4 years:

Column 1 Column 2 Column 3 Column 4 Column 5

1 Description
FY15
’000
FY14
’000
FY13
’000
FY12
’000

2 FOREX gain/loss
-64,117
-15,118
-29,838
-47,361

3 NPAT
-69,848
151
-53,160
841

It is amazing to see what an impact FX has on Wellard’s profitability, which begs a question why is their hedging so poor. Good people of HotCopper who follow this company more closely could you please shed some light on this.

Kind Regards,
Ed

Expand

Hi Ed , Gone into a Trading Halt and all will be revealed very soon. FX losses had been mentioned

in earlier reports from the company.

I doubt the announcement coming will be good ??

WLD Price at posting: 59.5¢ Sentiment: None Disclosure: Held

Upvote

0 Great analysis

Top Stories

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

PL3

Patagonia looks to raise $2.15M for South American exploration and development

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

There are more pages in this discussion • 52 more messages in this thread...

First 2 Last

Add WLD (ASX) to my watchlist

(20min delay)
Last 4.3¢		Change 0.003(7.50%)		Mkt cap ! $22.84M

Open	High	Low	Value	Volume
4.2¢	4.3¢	4.2¢	$17.25K	407.1K

Buyers (Bids)

No.	Vol.	Price($)
1	1223202	4.2¢

Sellers (Offers)

Price($)	Vol.	No.
4.3¢	30964	1

View Market Depth

No.	Vol.	Price($)
1	1223202	0.042
1	5000	0.040
1	51282	0.039
2	415024	0.038
1	100000	0.037

Price($)	Vol.	No.
0.043	30964	1
0.044	200000	1
0.046	123468	2
0.047	18799	1
0.048	1835722	1

Last trade - 15.32pm 09/07/2024 (20 minute delay)

WLD (ASX) Chart

Wellard Foreign exchange loss, page-2

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

	Column 1	Column 2	Column 3	Column 4	Column 5
1	Description	FY15 ’000	FY14 ’000	FY13 ’000	FY12 ’000
2	FOREX gain/loss	-64,117	-15,118	-29,838	-47,361
3	NPAT	-69,848	151	-53,160	841

Wellard Foreign exchange loss, page-2

Top Stories

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News